Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AGIOS-PHARMACEUTICALS-INC-13709228/news/One-Year-Safety-and-Efficacy-of-Mitapivat-in-Sickle-Cell-Disease-Follow-Up-Results-of-a-Phase-2-Op-45592821/?utm_source=whatsapp&utm_medium=social&utm_campaign=share